SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0001213900-22-072942
Filing Date
2022-11-16
Accepted
2022-11-15 20:42:59
Documents
1
Group Members
JOSEPH REDA C/F ANGUS PATRICK DEENEY UTMA/NYJOSEPH REDA C/F CLAIRE ESTIE DEENEY UTMA/NYJOSEPH REDA C/F DUSTIN RUSSELL REDA UTMA/NYJOSEPH REDA C/F JOSEPH WILLIAM REDA UTMA/NYSPECIAL EQUITIES OPPORTUNITY FUND, LLC

Document Format Files

Seq Description Document Type Size
1 SCHEDULE 13G ea168797-13greda_silo.htm SC 13G 101181
  Complete submission text file 0001213900-22-072942.txt   103031
Mailing Address 560 SYLVAN AVE SUITE 3160 ENGLEWOOD CLIFFS NJ 07632
Business Address 560 SYLVAN AVE SUITE 3160 ENGLEWOOD CLIFFS NJ 07632 (718) 400-9031
Silo Pharma, Inc. (Subject) CIK: 0001514183 (see all company filings)

IRS No.: 462137136 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-87110 | Film No.: 221392748
SIC: 2300 Apparel & Other Finishd Prods of Fabrics & Similar Matl

Mailing Address 1324 MANOR CIRCLE PELHAM NY 10803
Business Address
Reda Joseph (Filed by) CIK: 0001952100 (see all company filings)

Type: SC 13G